These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 24412186)

  • 21. Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging.
    Kristen AV; aus dem Siepen F; Scherer K; Kammerer R; Andre F; Buss SJ; Bauer R; Lehrke S; Voss A; Giannitsis E; Katus HA; Steen H
    Amyloid; 2015; 22(2):132-41. PubMed ID: 26053103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study.
    Fontana M; Banypersad SM; Treibel TA; Abdel-Gadir A; Maestrini V; Lane T; Gilbertson JA; Hutt DF; Lachmann HJ; Whelan CJ; Wechalekar AD; Herrey AS; Gillmore JD; Hawkins PN; Moon JC
    Radiology; 2015 Nov; 277(2):388-97. PubMed ID: 25997029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis.
    Dohy Z; Szabo L; Pozsonyi Z; Csecs I; Toth A; Suhai FI; Czimbalmos C; Szucs A; Kiss AR; Becker D; Merkely B; Vago H
    PLoS One; 2022; 17(6):e0269807. PubMed ID: 35696411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.
    Boynton SJ; Geske JB; Dispenzieri A; Syed IS; Hanson TJ; Grogan M; Araoz PA
    JACC Cardiovasc Imaging; 2016 Jun; 9(6):680-6. PubMed ID: 27209101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Native T1 mapping in transthyretin amyloidosis.
    Fontana M; Banypersad SM; Treibel TA; Maestrini V; Sado DM; White SK; Pica S; Castelletti S; Piechnik SK; Robson MD; Gilbertson JA; Rowczenio D; Hutt DF; Lachmann HJ; Wechalekar AD; Whelan CJ; Gillmore JD; Hawkins PN; Moon JC
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):157-65. PubMed ID: 24412190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.
    Mekinian A; Lions C; Leleu X; Duhamel A; Lamblin N; Coiteux V; De Groote P; Hatron PY; Facon T; Beregi JP; Hachulla E; Launay D;
    Am J Med; 2010 Sep; 123(9):864-8. PubMed ID: 20800158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Assessment of Cardiac Amyloidosis by Myocardial Strain Analysis of Cardiac Magnetic Resonance Imaging.
    Oda S; Utsunomiya D; Nakaura T; Yuki H; Kidoh M; Morita K; Takashio S; Yamamuro M; Izumiya Y; Hirakawa K; Ishida T; Tsujita K; Ueda M; Yamashita T; Ando Y; Hata H; Yamashita Y
    Circ J; 2017 Jun; 81(7):1014-1021. PubMed ID: 28367859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
    Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
    Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
    Brownrigg J; Lorenzini M; Lumley M; Elliott P
    ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
    Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
    Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis.
    Ruberg FL; Appelbaum E; Davidoff R; Ozonoff A; Kissinger KV; Harrigan C; Skinner M; Manning WJ
    Am J Cardiol; 2009 Feb; 103(4):544-9. PubMed ID: 19195518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiac amyloidosis--cardiovascular magnetic resonance imaging as a valuable diagnostic tool].
    Braun G; Sechtem U; Mahrholdt H
    Dtsch Med Wochenschr; 2009 Apr; 134(15):734-7. PubMed ID: 19340749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinctive Patterns of Transthyretin Amyloid in Salivary Tissue: A Clinicopathologic Study of 92 Patients With Amyloid-containing Minor Salivary Gland Biopsies.
    Jamet MP; Gnemmi V; Hachulla É; Dhaenens CM; Bouchindhomme B; Delattre C; Glowacki F; Hatron PY; Lacour A; Lamblin N; Launay D; Leleu X; Guiochon-Mantel A; Valleix S; Maurage CA; Copin MC; Buob D
    Am J Surg Pathol; 2015 Aug; 39(8):1035-44. PubMed ID: 25828388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac transthyretin amyloidosis.
    Dungu JN; Anderson LJ; Whelan CJ; Hawkins PN
    Heart; 2012 Nov; 98(21):1546-54. PubMed ID: 22888163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Late enhancement of cardiac MRI in patients with suspicious cardiacamyloid].
    Sun JY; Zhang Q; Cheng W; Chen YC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):941-4. PubMed ID: 23387233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
    Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of cardiac amyloidosis incidentally detected by bone scintigraphy.
    Tanaka H; Hosono M; Kanagaki M; Shimizu M; Matsubara N; Kawabata K; Miyamoto T; Itoi K
    Asia Ocean J Nucl Med Biol; 2021; 9(1):71-75. PubMed ID: 33392354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Prognostic Value of Query Amyloid Late Enhancement Score in Light-Chain Cardiac Amyloidosis.
    Wan K; Sun J; Han Y; Liu H; Yang D; Li W; Wang J; Cheng W; Zhang Q; Zeng Z; Chen Y
    Circ J; 2018 Feb; 82(3):739-746. PubMed ID: 29093431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases.
    Larsen BT; Mereuta OM; Dasari S; Fayyaz AU; Theis JD; Vrana JA; Grogan M; Dogan A; Dispenzieri A; Edwards WD; Kurtin PJ; Maleszewski JJ
    Histopathology; 2016 Apr; 68(5):648-56. PubMed ID: 26212778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.